Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LJPC message board posts where the ticker symbol LJPC has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LJPC SEC Filings

Filings Format Description Filing Date File/Film Number
10-K  Documents   Interactive Data Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0000920465-18-000007 (34 Act)  Size: 5 MB
2018-02-22 001-36282
18633252
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001012975-18-000214 Size: 8 KB
2018-02-20
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001012975-18-000199 Size: 10 KB
2018-02-15
5  Documents Annual statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-004076 Size: 7 KB
2018-02-14
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001085146-18-000752 (34 Act)  Size: 57 KB
2018-02-14 005-44849
18608221
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001493152-18-002066 (34 Act)  Size: 194 KB
2018-02-14 005-44849
18607735
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000315066-18-001371 (34 Act)  Size: 9 KB
2018-02-13 005-44849
18599918
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000038777-18-000091 (34 Act)  Size: 195 KB
2018-02-07 005-44849
18580301
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000812295-18-000011 (34 Act)  Size: 7 KB
2018-02-06 005-44849
18577487
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000053417-18-000039 (34 Act)  Size: 8 KB
2018-02-05 005-44849
18574084
More LJPC SEC Filings


Related news from
Fri, 23 Feb 2018
10:02:14 +0000
La Jolla Pharmaceutical posts 4Q loss
On a per-share basis, the San Diego-based company said it had a loss of $1.74. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was ...
Thu, 22 Feb 2018
22:17:08 +0000
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress
SAN DIEGO, Calif., Feb. 22, 2018-- La Jolla Pharmaceutical Company, a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening ...
Wed, 21 Feb 2018
14:00:00 +0000
La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study
SAN DIEGO, Feb. 21, 2018-- La Jolla Pharmaceutical Company today announced that the first pediatric patient has been treated in LJ501-CRH02, La Jolla’ s open-label study of GIAPREZA TM, injection for intravenous ...
Mon, 12 Feb 2018
21:35:00 +0000
Why Lumber Liquidators Holdings, Stamps.com, and La Jolla Pharmaceutical Slumped Today
The market soared, but these stocks got left behind. Find out why.
Mon, 12 Feb 2018
16:04:32 +0000
Jefferies Downgrades La Jolla On Weak Forecast For Blood Pressure Drug
In the absence of a potential buyout, the downside risk for La Jolla Pharmaceutical Company (NASDAQ: LJPC ) is greater than the upside potential in the next two to three years, according to Jefferies.  ...
Fri, 02 Feb 2018
19:39:11 +0000
What You Must Know About La Jolla Pharmaceutical Company’s (NASDAQ:LJPC) Financial Health
La Jolla Pharmaceutical Company (NASDAQ:LJPC), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off isRead More...
Wed, 24 Jan 2018
13:00:00 +0000
Consolidated Research: 2018 Summary Expectations for Freshpet, eHealth, SEACOR, La Jolla Pharmaceutical, Rogers, and On Assignment — Fundamental Analysis, Key Performance Indications
NEW YORK, Jan. 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Freshpet, ...
Wed, 03 Jan 2018
08:00:00 +0000
La Jolla Pharmaceutical Hits 80-Plus Relative Strength Rating Benchmark
La Jolla Pharmaceutical sees its Relative Strength Rating reach the 80-plus level.
Sat, 30 Dec 2017
02:00:00 +0000
3 Biotechs Launching Their First Commercial Drugs in 2018
New drugs with multibillion-dollar market opportunities will hit pharmacy shelves in 2018.
Thu, 28 Dec 2017
12:19:06 +0000
La Jolla Pharmaceutical Co. is trading above its 50 day moving average : LJPC-US : December 28, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Tue, 26 Dec 2017
13:36:01 +0000
La Jolla Pharmaceutical (LJPC) Surges: Stock Moves 11.1% Higher
The shares of La Jolla Pharmaceutical (LJPC) rose 11.1% on Friday
Fri, 22 Dec 2017
21:13:13 +0000
Christmas Comes Early For These 5 Biotechnology Stocks
Biotech stocks rallied on Friday amid a strategic acquisition by Swiss drug maker Roche and regulatory approvals.
Fri, 22 Dec 2017
17:20:14 +0000
What the Latest Approval Means for La Jolla Pharmaceutical
A look at the latest regulatory approval in the US
Fri, 22 Dec 2017
17:16:00 +0000
Here's Why La Jolla Pharmaceutical Shares Are Surging 12.5% Higher Today
The FDA surprised the biopharmaceutical with good news today.
Thu, 21 Dec 2017
23:36:21 +0000
La Jolla stock jumps 16% after FDA approval
La Jolla Pharmaceutical Co. rose more than 16% Thursday afternoon after the company announced it had received approval for a new drug to increase blood pressure. The drug, Giapreza, is used to treat patients ...
Thu, 21 Dec 2017
23:35:57 +0000
FDA approves La Jolla's low blood pressure drug
La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure. The company said it plans to make Giapreza available for patients in the United States in March. La Jolla's shares rose 4.2 percent to $32.45 in extended trading on Thursday.
Thu, 21 Dec 2017
23:15:00 +0000
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)
Giapreza increases blood pressure in adults with septic or other distributive shock. La Jolla to host conference call and webcast at 8:30 a.m. EST on December 22, 2017. SAN DIEGO, Dec. 21, 2017-- La Jolla ...
Thu, 21 Dec 2017
16:58:10 +0000
Analyst: La Jolla Pharma A Buy Ahead Of February FDA Date
La Jolla Pharmaceutical Company (NASDAQ: LJPC ) has an upcoming catalyst in the form of a Feb. 28 PDUFA date. An analyst at H.C. Wainwright recommends buying of the shares ahead of the decision.  The Analyst ...
Tue, 19 Dec 2017
10:35:00 +0000
[$$] 5 Biotech Stocks a Pro Is Buying
Joseph Edelman, the founder of Perceptive Advisors and its hedge fund, Perceptive Life Sciences, managed to secure a nearly 4% gain in 2016’s rout. Perceptive now owns 3.4 million shares of La Jolla, a 15.3% stake, up from 2.2 million shares, or 9.7%, at Sept. 30.
Mon, 18 Dec 2017
14:00:00 +0000
La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis
SAN DIEGO, Dec. 18, 2017-- La Jolla Pharmaceutical Company today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC‑ 401 in patients with hereditary hemochromatosis. The most common ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is an awesome community of bright, serious, passionate and involved individual investors. Information is well organized into fine-grained topics and discussions are always on topic and relevant. People here certainly know what value is and this site itself is a great reflection of that. I feel honored and privileged to have found such a great resource and to be part of it!" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards